Zomedica Corp
AMEX:ZOM
Intrinsic Value
The intrinsic value of one ZOM stock under the Base Case scenario is 0.153 USD. Compared to the current market price of 0.0528 USD, Zomedica Corp is Undervalued by 65%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Zomedica Corp
Fundamental Analysis

Revenue & Expenses Breakdown
Zomedica Corp
Balance Sheet Decomposition
Zomedica Corp
Current Assets | 87.3m |
Cash & Short-Term Investments | 76.9m |
Receivables | 2.4m |
Other Current Assets | 8m |
Non-Current Assets | 126.8m |
Long-Term Investments | 966k |
PP&E | 27.4m |
Intangibles | 97.2m |
Other Non-Current Assets | 1.3m |
Free Cash Flow Analysis
Zomedica Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Zomedica Corp
Revenue
|
26.7m
USD
|
Cost of Revenue
|
-8.1m
USD
|
Gross Profit
|
18.6m
USD
|
Operating Expenses
|
-56.9m
USD
|
Operating Income
|
-38.3m
USD
|
Other Expenses
|
-23.9m
USD
|
Net Income
|
-62.2m
USD
|
ZOM Profitability Score
Profitability Due Diligence
Zomedica Corp's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Zomedica Corp's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
ZOM Solvency Score
Solvency Due Diligence
Zomedica Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Zomedica Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ZOM Price Targets Summary
Zomedica Corp
According to Wall Street analysts, the average 1-year price target for ZOM is 0.255 USD with a low forecast of 0.2525 USD and a high forecast of 0.2625 USD.
Dividends
Current shareholder yield for ZOM is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ZOM stock under the Base Case scenario is 0.153 USD.
Compared to the current market price of 0.0528 USD, Zomedica Corp is Undervalued by 65%.